CJC-1295 + Ipamorelin (No DAC)

UPS delivery across the EU

62.00

COA
Buy Now
Stock up & save
1 Vial
10% Off
2 Vials
15% Off
3 Vials
20% Off
5 Vials
30% Off
Kit (10 Vials)
Research Use Only: These products are intended for laboratory research purposes only. By purchasing, you confirm you are a qualified researcher and understand this product is not for personal use.
We accept
Visa
Mastercard
Google Pay
SEPA
iDEAL
Bitcoin
Ethereum
USDT

Description

CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin is a research-grade dual-peptide formulation combining two compounds that work through different pathways to stimulate growth hormone (GH) release. Both have been studied in preclinical and early clinical research for their complementary effects on the body’s GH system.

CJC-1295

  • A synthetic peptide that mimics the body’s natural growth hormone-releasing hormone (GHRH), engineered to last significantly longer in the body than its natural counterpart
  • Signals the pituitary gland to produce and release GH and IGF-1 in a sustained, natural-feeling pattern
  • Research has documented a half-life of 5.8–8.1 days, with IGF-1 levels remaining elevated for up to 28 days after repeated dosing (Teichman et al., 2006)

Ipamorelin

  • A short synthetic peptide that selectively triggers GH release from the pituitary gland by mimicking ghrelin, a naturally occurring hormone
  • Notably selective — research shows it does not stimulate stress hormones such as cortisol, even at very high doses, setting it apart from similar compounds (Raun et al., 1998)
  • GH release is driven through well-characterised intracellular signalling pathways (Sinha et al., 2020)

Combined Research Utility

Because the two peptides work through separate pathways, researchers can study the effects of stimulating GH through both routes simultaneously within a single experimental protocol. GH release patterns remain natural and pulsatile under this combined stimulation (Ionescu & Frohman, 2006).

For research use only. Not intended for use in humans or animals.

References

Ionescu, M., & Frohman, L. A. (2006). https://pubmed.ncbi.nlm.nih.gov/17018654/

Raun, K., Hansen, B. S., Johansen, N. L., Thøgersen, H., Madsen, K., Ankersen, M., & Christiansen, P. H. (1998). https://pubmed.ncbi.nlm.nih.gov/9849822/

Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/

Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J.-P., & Frohman, L. A. (2006). https://pubmed.ncbi.nlm.nih.gov/16352683/

Additional information

Size

10mg/vial

What are peptides?

Peptides are short chains of amino acids that act as signalling molecules in the body, playing a role in a wide range of biological processes including tissue repair, immune response, and cellular communication.

How are peptides used in research?

In research settings, peptides are studied for their ability to interact with specific receptors and biological pathways. This makes them valuable tools for scientific and laboratory analysis, helping researchers better understand how the body functions at a cellular level.

What payment methods do you accept?

We currently accept Credit Card, SEPA bank transfer, iDeal, Google Pay, Apple Pay, and Cryptocurrency (Bitcoin, Ethereum, and USDT).

How should I store my peptides?

All peptides are supplied in lyophilised (freeze-dried) form, ensuring stability during shipping and long-term storage. Unreconstituted vials should be kept in a cool, dry place away from direct light, with refrigeration recommended for extended periods. Once reconstituted for research purposes, peptides should be kept refrigerated and handled using sterile laboratory practices to maintain integrity throughout use.

How does shipping and delivery work?

Orders are processed and dispatched within 2 weeks of purchase. Shipping takes 48 hours through UPS Express Shipping. Order tracking is available directly on our website. Free shipping is applied automatically on all orders over €180.

Do you offer refunds or returns?

Due to the nature of research products, we are unable to accept returns. However if your order arrives damaged or incorrect please contact us within 48 hours.

How can I be sure of product quality?

All our products are lab-tested to ensure high purity and compliance with research-grade quality standards.

CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin is a research-grade dual-peptide formulation combining two compounds that work through different pathways to stimulate growth hormone (GH) release. Both have been studied in preclinical and early clinical research for their complementary effects on the body’s GH system.

CJC-1295

  • A synthetic peptide that mimics the body’s natural growth hormone-releasing hormone (GHRH), engineered to last significantly longer in the body than its natural counterpart
  • Signals the pituitary gland to produce and release GH and IGF-1 in a sustained, natural-feeling pattern
  • Research has documented a half-life of 5.8–8.1 days, with IGF-1 levels remaining elevated for up to 28 days after repeated dosing (Teichman et al., 2006)

Ipamorelin

  • A short synthetic peptide that selectively triggers GH release from the pituitary gland by mimicking ghrelin, a naturally occurring hormone
  • Notably selective — research shows it does not stimulate stress hormones such as cortisol, even at very high doses, setting it apart from similar compounds (Raun et al., 1998)
  • GH release is driven through well-characterised intracellular signalling pathways (Sinha et al., 2020)

Combined Research Utility

Because the two peptides work through separate pathways, researchers can study the effects of stimulating GH through both routes simultaneously within a single experimental protocol. GH release patterns remain natural and pulsatile under this combined stimulation (Ionescu & Frohman, 2006).

For research use only. Not intended for use in humans or animals.

References

Ionescu, M., & Frohman, L. A. (2006). https://pubmed.ncbi.nlm.nih.gov/17018654/

Raun, K., Hansen, B. S., Johansen, N. L., Thøgersen, H., Madsen, K., Ankersen, M., & Christiansen, P. H. (1998). https://pubmed.ncbi.nlm.nih.gov/9849822/

Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/

Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J.-P., & Frohman, L. A. (2006). https://pubmed.ncbi.nlm.nih.gov/16352683/